Bio-Rad Laboratories, Inc.Class A BIO

$361.19 -0.25% at last close

Recent SEC Filings

FormDescriptionFiledDocument
10-Q 10-Q 2026-08-04 View →
8-K 8-K 2026-08-04 View →
4 FORM 4 2026-07-28 View →
4 FORM 4 2026-05-13 View →
10-Q 10-Q 2026-04-30 View →
8-K 8-K 2026-04-30 View →
4 FORM 4 2026-04-28 View →
4 FORM 4 2026-04-28 View →
8-K 8-K 2026-04-24 View →
4 FORM 4 2026-04-23 View →
4 FORM 4 2026-04-23 View →
4 FORM 4 2026-04-23 View →
4 FORM 4 2026-04-23 View →
DEF 14A DEFINITIVE PROXY STATEMENT 2026-03-25 View →
8-K 8-K 2026-02-19 View →
10-K 10-K 2026-02-13 View →
8-K 8-K 2026-02-12 View →
4 FORM 4 2025-11-10 View →
10-Q 10-Q 2025-10-29 View →
8-K 8-K 2025-10-29 View →
4 FORM 4 2025-10-28 View →
4 FORM 4 2025-10-21 View →
8-K 8-K 2025-09-30 View →
4 FORM 4 2025-09-09 View →
4 FORM 4 2025-09-09 View →
4 FORM 4 2025-09-09 View →
4 FORM 4 2025-09-09 View →
4 FORM 4 2025-09-09 View →
4 FORM 4 2025-09-09 View →
4 FORM 4 2025-09-09 View →
4 FORM 4 2025-09-09 View →
4 FORM 4 2025-09-09 View →
4 FORM 4 2025-09-09 View →
4 FORM 4 2025-09-03 View →
4 FORM 4 2025-09-03 View →
4 FORM 4 2025-09-03 View →
4 FORM 4 2025-09-03 View →
8-K 8-K 2025-08-26 View →
10-Q 10-Q 2025-07-31 View →
8-K 8-K 2025-07-31 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$361.19
Market Cap
$9.68 billion
52-Week Range
$236.73 – $365.00
Average Volume
298K shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.